Alerts will be sent to your verified email
Verify EmailJUBLINGREA
Jubilant Ingrevia
|
Fairchem Organics
|
Alivus Life Sciences
|
|
---|---|---|---|
Operational Metrics
|
|||
Chemical Sector
|
|||
Capacity Utilization - Speciality Chemicals
|
74.0 % | 75.0 % | n/a |
Manufacturing Capacity - Speciality Chemicals
|
72000.0 MTPA | 120000.0 MTPA | n/a |
Capacity Utilization - Nutrition & Health Solutions
|
70.0 % | n/a | n/a |
Capacity Utilization - Life Science Chemicals
|
69.0 % | n/a | n/a |
Financials
|
|||
5 yr Average ROE
|
9.84 % | 18.49 % | 25.27 % |
5yr average Equity Multiplier
|
1.66 | 1.35 | 1.74 |
5yr Average Asset Turnover Ratio
|
0.87 | 1.72 | 0.71 |
5yr Avg Net Profit Margin
|
6.89 % | 7.72 % | 20.19 % |
Price to Book
|
3.82 | 3.62 | 4.15 |
P/E
|
40.26 | 117.44 | 23.6 |
5yr Avg Cash Conversion Cycle
|
-3.44 Days | 90.64 Days | 100.66 Days |
Inventory Days
|
124.69 Days | 41.64 Days | 95.06 Days |
Days Receivable
|
51.39 Days | 48.07 Days | 132.12 Days |
Days Payable
|
164.38 Days | 9.62 Days | 120.47 Days |
5yr Average Interest Coverage Ratio
|
14.0 | 11.33 | 371.82 |
5yr Avg ROCE
|
13.27 % | 24.26 % | 33.88 % |
5yr Avg Operating Profit Margin
|
13.6 % | 12.71 % | 29.64 % |
5 yr average Debt to Equity
|
0.21 | 0.21 | 0.0 |
5yr CAGR Net Profit
|
35.81 % | -12.35 % | 6.67 % |
5yr Average Return on Assets
|
6.07 % | 13.53 % | 14.28 % |
Shareholdings
|
|||
Promoter Holding
|
45.22 % | 61.19 % | 74.94 % |
Share Pledged by Promoters
|
2.22 % | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-6.25 % | 2.31 % | -7.91 % |
Change in Mutual Fund Holding (3 Yrs)
|
19.5 % | 0.0 | 3.35 % |
Jubilant Ingrevia
|
Fairchem Organics
|
Alivus Life Sciences
|
|
---|---|---|---|
Segment Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
-
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Verticals
|
Verticals
|
-
|
-
|
Capex
|
Capex
|
-
|
-
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
Asset Break-Up - Segment Wise
|
Asset Break-Up - Segment Wise
|
-
|
-
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|